Single and multidose pharmacokinetic study of a vaginal micronized progesterone insert (Endometrin) compared with vaginal gel in healthy reproductive-aged female subjects
To access this article, please choose from the options below
E.J.B. has nothing to disclose. P.M.N. has nothing to disclose. S.F.D. has nothing to disclose. J.L. has nothing to disclose. V.I.Y. has nothing to disclose.
Supported by Ferring Pharmaceuticals, Inc., of Parsippany, NJ.
PII: S0015-0282(09)01311-9
doi:10.1016/j.fertnstert.2009.06.014
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

